The Export Control (Amendment) (No. 3) Order 2010
Jurisdiction | UK Non-devolved |
Citation | SI 2010/2843 |
Year | 2010 |
2010 No. 2843
Customs
The Export Control (Amendment) (No. 3) Order 2010
Made 29th November 2010
Laid before Parliament 29th November 2010
Coming into force 30th November 2010
The Secretary of State, in exercise of the powers conferred by sections 1, 6 and 7 of the Export Control Act 20021, makes the following Order:
Citation, commencement and expiration
1.—(1) This Order may be cited as the Export Control (Amendment) (No.3) Order 2010.
(2) It comes into force on 30th November 2010.
(3) It ceases to have effect on 28th November 2011.
Amendments related to pharmaceutical goods
2.—(1) The Export Control Order 20082is amended as follows.
(2) After Article 4 insert—
“Movement of Thiopental Sodium to the United States of America
4A.—(1) Subject to articles 17 and 26, no person shall export pharmaceutical goods for human use containing the active ingredient thiopental sodium if paragraph (2) or (3) applies.
(2) This paragraph applies where the destination is the United States of America.
(3) This paragraph applies where the destination is not the United States of America but the exporter knows that the final destination of the goods is the United States of America.”.
(3) In article 17 (transit or transhipment exception), in sub-paragraph (1) after “4,” insert “4A,”.
(4) In paragraphs (1)(a)(i) and (2)(a) of article 41 (application of CEMA in respect of offences), after “4,” insert “4A,”.
Mark Prisk
Minister of State for Business Enterprise
Department for Business, Innovation and Skills
29th November 2010
EXPLANATORY NOTE
(This note is not part of the Order)
This Order amends the Export Control Order 2008 ( S.I. 2008/3231). Article 2 introduces a new control on the export of pharmaceutical goods for human use containing the active ingredient thiopental sodium to the United States of America and makes other related amendments. This Order will cease to have effect on 28 November 2011.
The Explanatory Memorandum is available alongside the instrument on the OPSI website. The Impact Assessment is currently being prepared.
To continue reading
Request your trial